123 related articles for article (PubMed ID: 70889)
1. [Clinical observations on the use of high-dose methotrexate treatment in osteogenic sarcoma (author's transl)].
Kotz R; Leber H; Ramach W; Arbes H; Wolf A
Wien Klin Wochenschr; 1977 Jul; 89(14):474-9. PubMed ID: 70889
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
[TBL] [Abstract][Full Text] [Related]
3. Selected applications of methotrexate alone and in combination in osteosarcoma.
Pratt CB
Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
[TBL] [Abstract][Full Text] [Related]
4. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
Rosen G; Huvos AG; Marcove R; Nirenberg A
Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
[TBL] [Abstract][Full Text] [Related]
5. High-dose methotrexate with citrovorum factor in osteogenic sarcoma--progress report II.
Jaffe N; Frei E; Traggis D; Cassady JR; Watts H; Filler RM
Cancer Treat Rep; 1977 Jul; 61(4):675-9. PubMed ID: 301780
[TBL] [Abstract][Full Text] [Related]
6. [Therapeutic results of patients with osteogenic sarcoma by the protocol COSS 77 (author's transl)].
Prindull G; Poppe H; Jentsch E; Schauer A
Unfallheilkunde; 1981 Dec; 84(12):524-5. PubMed ID: 6948465
[No Abstract] [Full Text] [Related]
7. Adjuvant chemotherapy for osteogenic sarcoma.
Etcubanas E; Wilbur JR
Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
[TBL] [Abstract][Full Text] [Related]
8. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
[TBL] [Abstract][Full Text] [Related]
9. Sequential combination chemotherapy (containing high-dose cyclophosphamide) for metastic osteogenic sarcoma.
Levine AS; Appelbaum FR; Graw RG; Magrath IT; Pizzo PA; Poplack DG; Ziegler JL
Cancer Treat Rep; 1978 Feb; 62(2):247-50. PubMed ID: 346213
[TBL] [Abstract][Full Text] [Related]
10. [Aggressive cytostatic treatment of osteogenic sarcoma in childhood (author's transl)].
Pontz BF; Gutjahr P
Dtsch Med Wochenschr; 1981 Feb; 106(7):200-7. PubMed ID: 6937343
[No Abstract] [Full Text] [Related]
11. Delayed methotrexate clearance in osteosarcoma patients treated with multiagent regimens of neoadjuvant chemotherapy.
Bacci G; Ferrari S; Longhi A; Forni C; Loro L; Beghelli C; Tremosini M; Versari M
Oncol Rep; 2003; 10(4):851-7. PubMed ID: 12792734
[TBL] [Abstract][Full Text] [Related]
12. [Alternative chemotherapy of malignant bone neoplasms in children].
Jurczyk-Procyk S; Perek D
Probl Med Wieku Rozwoj; 1990; 16():55-68. PubMed ID: 1726893
[TBL] [Abstract][Full Text] [Related]
13. [Controlled ultra-high dosage methotrexate therapy in three patients with metastatic osteosarcoma (author's transl)].
Leber H; Kotz R; Chiari K; Endler T; Gabl F; Krisch K; Salzer-Kuntschik M
Wien Klin Wochenschr; 1981 Apr; 93(7):236-40. PubMed ID: 7020262
[TBL] [Abstract][Full Text] [Related]
14. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
[TBL] [Abstract][Full Text] [Related]
15. Preoperative administration of high-dose methotrexate for osteosarcoma.
Chan KW; Knowling MA; Duncan CP; Morton KS
Can J Surg; 1984 May; 27(3):305-7, 309. PubMed ID: 6586272
[TBL] [Abstract][Full Text] [Related]
16. [Chemotherapy of osteosarcoma (author's transl)].
Winkler K; Gaedicke G; Grosch-Wörner I; Marsmann G; Delling G; Landbeck G
Dtsch Med Wochenschr; 1977 Dec; 102(50):1831-5. PubMed ID: 303980
[TBL] [Abstract][Full Text] [Related]
17. Adjuvant therapy for nonmetastatic osteogenic sarcoma: an evaluation of transfer factor versus combination chemotherapy.
Gilchrist GS; Ivins JC; Ritts RE; Pritchard DJ; Taylor WF; Edmonson JM
Cancer Treat Rep; 1978 Feb; 62(2):289-94. PubMed ID: 346219
[TBL] [Abstract][Full Text] [Related]
18. Methotrexate as a single agent and in combination chemotherapy for the treatment of non-Hodgkin's lymphoma of unfavorable histology.
Canellos GP; Skarin AT; Rosenthal DS; Moloney WC; Frei E
Cancer Treat Rep; 1981; 65 Suppl 1():125-9. PubMed ID: 6173118
[TBL] [Abstract][Full Text] [Related]
19. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
[TBL] [Abstract][Full Text] [Related]
20. High-dose methotrexate in osteogenic sarcoma: a 5-year experience.
Jaffe N; Frei E; Watts H; Traggis D
Cancer Treat Rep; 1978 Feb; 62(2):259-64. PubMed ID: 346215
[No Abstract] [Full Text] [Related]
[Next] [New Search]
